Literature DB >> 21895509

Cognitive screening in patients with amyotrophic lateral sclerosis in early stages.

Gianluca Floris1, Giuseppe Borghero, Adriano Chiò, Liz Secchi, Antonino Cannas, Claudia Sardu, Andrea Calvo, Cristina Moglia, Maria Giovanna Marrosu.   

Abstract

Few studies have examined the use of a short cognitive screening of ALS patients in order to establish which patients should undergo a more comprehensive neuropsychological assessment. We tested 20 patients with early ALS with four cognitive screening instruments and subsequently with an extensive neuropsychological assessment. Sixty percent of patients showed a deficit in at least two scores of tests administered, while 40% had three abnormal tests. Dysexecutive syndrome was the most common neuropsychological impairment. The Frontal Assessment Battery (FAB) proved a useful indicator of the presence of cognitive dysfunction to complete neuropsychological evaluation. In conclusion, the FAB can be considered a sensitive cognitive screening tool in these patients. These data will be verified on a larger sample of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21895509     DOI: 10.3109/17482968.2011.605453

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  10 in total

1.  FAB-D: German version of the Frontal Assessment Battery.

Authors:  Thomas Benke; Elfriede Karner; Margarete Delazer
Journal:  J Neurol       Date:  2013-05-07       Impact factor: 4.849

2.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.

Authors:  Lucio Tremolizzo; Andrea Lizio; Gabriella Santangelo; Susanna Diamanti; Christian Lunetta; Francesca Gerardi; Sonia Messina; Stefania La Foresta; Nilo Riva; Yuri Falzone; Massimo Filippi; Susan C Woolley; Valeria Ada Sansone; Mattia Siciliano; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2019-12-05       Impact factor: 3.307

Review 3.  Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review.

Authors:  Tina Taule; Margaret Søvik; Regina Küfner Lein; Eike Wehling; Jörg Aßmus; Tiina Rekand
Journal:  Patient Relat Outcome Meas       Date:  2020-09-22

4.  Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China.

Authors:  QianQian Wei; XuePing Chen; ZhenZhen Zheng; Rui Huang; XiaoYan Guo; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

5.  Suicidal Behavior and Neurological Illnesses.

Authors:  Steven S Coughlin; Leo Sher
Journal:  J Depress Anxiety       Date:  2013-04-18

6.  The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population.

Authors:  Shan Ye; Ying Ji; Chengyu Li; Ji He; Xiaolu Liu; Dongsheng Fan
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

7.  Frontal assessment battery and frontal atrophy in amyotrophic lateral sclerosis.

Authors:  Tatsuhiro Terada; Jun Miyata; Tomokazu Obi; Manabu Kubota; Miho Yoshizumi; Kinya Yamazaki; Kouichi Mizoguchi; Toshiya Murai
Journal:  Brain Behav       Date:  2017-04-12       Impact factor: 2.708

8.  Prospective memory tasks: a more sensitive method for screening cognitive impairment in ALS?

Authors:  Ying Ji; Ling Wei; Dehua Chui; Kai Wang; Dongsheng Fan
Journal:  BMC Neurol       Date:  2012-11-21       Impact factor: 2.474

9.  Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study.

Authors:  Maria Rosaria Barulli; Andrea Fontana; Francesco Panza; Massimiliano Copetti; Stefania Bruno; Marianna Tursi; Annalisa Iurillo; Rosanna Tortelli; Rosa Capozzo; Isabella Laura Simone; Giancarlo Logroscino
Journal:  BMJ Open       Date:  2015-09-03       Impact factor: 2.692

10.  Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Authors:  Seong-il Oh; Aram Park; Hee-Jin Kim; Ki-Wook Oh; Hojin Choi; Min-Jung Kwon; Chang-Seok Ki; Hee-Tae Kim; Seung Hyun Kim
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.